ArticleBMC cancer2014

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis.

Klaus Mross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.